1-4 of 4
Andrea Varga, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Is Molecular Characterization Useful for Targeted Therapy Orientation in Patients with Relapsed or Refractory DLBCL Included in Early Phase Clinical Trials?

Jean-Marie Michot, MD, Valérie Camara-Clayette, PhD, Cyril Quivoron, PhD, Alina Danu, MD, Julien Lazarovici, MD, David Ghez, MD PhD, Julien Rossignol, MD PhD, Capucine Baldini, MD, Patricia Martin-Romano, MD PhD, Clementine Sarkozy, MD PhD, Andrea Varga, MD, Helene Lecourt, Veronique Vergé, MD, Sophie Cotteret, MD PhD, Peggy Dartigues-Cuillères, MD, Christophe Massard, MD PhD, Vincent Ribrag, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 18–19.
https://doi.org/10.1182/blood-2020-136134
Published: 2020
Journal Articles

High Incidence of TP53 and Epigenetic Modifying Oncogenes Mutations in a Large Cohort of Patients Enrolled in Phase 1 Clinical Trials for Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Cyril Quivoron, PhD, Jean-Marie Michot, MD, Valérie Camara-clayette, PhD, Alina Danu, MD, Julien Lazarovici, MD, Clementine Sarkozy, MD PhD, David Ghez, MD PhD, Julien Rossignol, MD PhD, Capucine Baldini, MD, Patricia Martin-Romano, MD PhD, Helene Lecourt, Veronique Vergé, MD, Andrea Varga, MD, Sophie Cotteret, MD PhD, Peggy Dartigues-Cuillères, MD, Christophe Massard, MD PhD, Vincent Ribrag, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 10–11.
https://doi.org/10.1182/blood-2020-136114
Published: 2020
Journal Articles

A Simple Scoring System for Identifying Relapsed/Refractory Lymphoma Patients Prematurely Withdrawn from Phase I Trials: The Gustave Roussy Experience

Lina Benajiba, MD, Capucine Baldini, MD, Laura Faivre, Jean-Marie Michot, MD, Andrea Varga, MD, Christophe Willekens, Camille Bigenwald, MD, Rastislav Bahleda, MD, Anas Gazzah, MD, Jean-Charles Soria, MD PhD, Vincent Ribrag, MD
Journal: Blood
Blood (2014) 124 (21): 1759.
https://doi.org/10.1182/blood.V124.21.1759.1759
Published: 2014
Journal Articles

Prognostic Factors and Outcome of Patients with Hematological Malignancies in Phase I Trials: The Gustave Roussy Scoring System

Lina Benajiba, MD, Capucine Baldini, MD, Laura Faivre, Jean-Marie Michot, MD, Andrea Varga, MD, Rastislav Bahleda, MD, Anas Gazzah, MD, Stéphane de Botton, MD, Jean-Charles Soria, MD PhD, Vincent Ribrag, MD
Journal: Blood
Blood (2014) 124 (21): 3504.
https://doi.org/10.1182/blood.V124.21.3504.3504
Published: 2014